Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Ejhaem|July 8, 2026
Immune Effector Cell-Associated Hematotoxicity With Secondary Myelofibrosis Following Idecabtagene-Vicleucel for Multiple Myeloma, Comprehensively Treated With Autologous Hematopoietic Stem Cell BoostingKeishi Ogura, Takahiro Fujino, Takahisa Nakamura, et al.
Biochemical and Biophysical Research Communications|January 31, 2026
Multistep molecular trajectory of monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cellsYu Inoue, Yuji Shimura, Yui Niiyama-Uchibori, et al.
Infection and Drug Resistance|April 21, 2020
Tuberculosis Peritonitis During Treatment of Polycythemia Vera with RuxolitinibEmiko Sakiyama, Yoshiaki Chinen, Taku Tsukamoto, et al.
The Tohoku Journal of Experimental Medicine|June 21, 2021
Durable Remission of Chemotherapy-Refractory Myeloid Sarcoma by AzacitidineHaruya Okamoto, Yuri Kamitsuji, Yukiko Komori, et al.
Journal of Human Genetics|March 7, 2023
Imaging flow cytometry-based multiplex FISH for three IGH translocations in multiple myelomaTaku Tsukamoto, Masaki Kinoshita, Kazuhiro Yamada, et al.
Hematological Oncology|January 30, 2024
Skeletal muscle index impacts the treatment outcome of elderly patients with diffuse large B cell lymphomaYui Niiyama-Uchibori, Haruya Okamoto, Akihiro Miyashita, et al.
Neurologia Medico-Chirurgica|October 19, 2023
Analysis of False-negative Findings of the Incomparable Accuracy and Swiftness of Flow Cytometric Diagnosis of Primary Central Nervous System LymphomaHayato Takeuchi, Tohru Inaba, Yukiko Shishido-Hara, et al.
Internal Medicine (Tokyo, Japan)|October 7, 2021
Gastric Myeloid Sarcoma Mimicking a Scirrhous Gastric CancerYoko Taminishi-Katsuragawa, Yuji Shimura, Yu Inoue, et al.
Frontiers in Oncology|October 27, 2025
Case Report: Immunophenotypically diverse immature patterns, including variable TdT expression, in aggressive B-cell lymphomas and leukemia with MYC rearrangementDaishi Kato, Takahiro Fujino, Reiko Isa, et al.
Leukemia|October 22, 2024
Robust anti-myeloma effect of TAS0612, an RSK/AKT/S6K inhibitor, with venetoclax regardless of cytogenetic abnormalitiesHaruya Okamoto, Shinsuke Mizutani, Taku Tsukamoto, et al.
Pageof 8